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the CSF WCC/protein content to determine if this 
relationship continues and is sufficiently robust to allow 
selective HSV PCR sampling in the future. 
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INTRODUCTION 
Aeromonas (family Vibrionaceae) is a genus of Gram- 
negative non-sporulating facultative anaerobic rods that 
ferment carbohydrates [l]. It includes at  least 14 
genome species or DNA hybridization groups (HGs), 
from which 11 phenotypic species have been named 
[3]. The most clinically important phenospecies are A. 
hydrophila, A.  caviae, A. veronii and A. sobria (A. veronii 
biogroup sobria) [ 1,2]. Aeromonas spp. are generally 
found in temperate and tropical aquatic climates and are 
readily isolated from fresh and estuarine water, soil, 
animals and fish [1,2]. A high incidence of healthy fecal 
carriers has been observed :in Asia, whereas the 
incidence in Europe, including northern Sweden, is less 
than 1% [1,3]. The genus is associated with gastro- 
enteritis and it is well established that Aeromonas spp. 
produce enterotoxin [2]. The predominant cause of 
rare but often severe invasive infections in humans 
appears to be A.  hydrophila [1,2]. The majority of these 
patients showed underlying illness, especially chronic 
hepatobiliary disease [1,4]. 
Hafnia alvei (family Enterobacteriaceae) is a Gram- 
negative facultative anaerobe rod occurring in a variety 
of environmental sources [5-71. H. alvei is regarded as 
a commensal in the human gastrointestinal tract [6]. In 
one study, the bacterium was isolated from stool 
samples in 5% of 105 healthy residents of northern 
Sweden [3]. Hafnia is only rarely associated with 
human disease but has been implicated as a cause of 
diarrheal illness in children and travelers, from whom 
strains expressing the attachment-effacement gene of 
Escherichia coli have been isolated [6,7]. Here we report 
a case of acute cholecystitis in a woman with chronic 
lymphatic leukemia from whom both A. sobria and 
H. alvei were isolated in repeated cultures from bile. 
CASE REPORT 
The patient was a 67-year-old woman living on the 
coast of the Gulf of Bothnia (64" latitude north). Her 
husband was an enthusiastic sports fisher, fishing mainly 
in the estuary of the Ume5 river. The catches were 
regularly prepared by the patient, and fish dishes were 
served several times a week in the household. The 
patient had never traveled abroad. 
In April 1994 chronic lymphatic leukemia was 
diagnosed. Subsequently, the patient developed severe 
hemolytic anemia, and chemotherapy was initiated in 
1995. After remission, treatment was continued with 
steroids. In January 1996 she developed clinical signs of 
cholangitis and an endoscopic retrograde cholangio- 
graphic (ERC) papillotomy, and stone extraction 
was performed, after which the biliary symptoms 
subsided. 
The patient was readmitted in April 1997 with 
a 3-day history of fever and abdominal pain. O n  
adrmttance she was in good general condition. Physical 
examination revealed tenderness in the upper right 
abdomen. The C-reactive protein (CRP) level was 
85 mg/L ( < l o  mg/L) and the leukocyte count was 
1 0 . 6 ~  109/L. Serum bilirubin, alkaline phosphatase and 
serum aminotransferase levels were within the normal 
range, except for alanine transaminase, which was slightly 
raised to 1.26 (normal range 0.20-0.60 pkat/L). 
Ultrasound revealed a dilated gallbladder with wall 
thickening. Treatment with intravenous piperacillin/ 
tazobactam (4 g every 8 h) was initiated. Due to 
persistent high fever and clinical signs of peritonitis, a 
cholecystectomy was performed on the second day of 
hospitalization. A stone from the common duct was 
removed and T-tube drainage was left. Histopathologic 
examination showed an inflamed gallbladder. Recovery 
was swift and uneventful. Laboratory tests, including 
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CRP, were normalized. Antibiotic treatment was 
changed to oral cefadroxil (1 g every 12 h) 3 days later. 
A culture obtained from the gallbladder during the 
operation yielded growth of oxidase-positive p- 
hemolytic Gram-negative rods identified as A. sobria by 
the biochemical profile in the API 20 E (profile 
7247126) (bioMkrieux SA, Marcy l'Etoile, France). 
The isolate was not genotyped but identification was 
regarded as 'excellent', with 98% identification in the 
API 20 E system. In addition, a few non-hemolytic 
colonies were observed on blood agar plates. These 
bacteria were identified as H .  alvei in the API 20 E 
system (profile 51041 12). Both isolates were susceptible 
to cefuroxime, ciprofloxacin, co-trimoxazole, genta- 
micin, imipenem and piperacillin/tazobactam, but 
resistant to ampicillin and cefadroxil. Blood cultures 
were negative. 
A post-exploratory cholangiography on day 12 was 
normal and the T-tube was removed. A new culture 
from the T-tube yielded growth ofA. sobria and H. alvei 
with the same resistance pattern. Antibiotic treatment 
was changed to ciprofloxacin by mouth (500 mg every 
12 h). At this stage the patient lacked clinical signs 
of ongoing infection and she was discharged with 
ciprofloxacin for 1 week. 
DISCUSSION 
This is, to our knowledge, the first case of invasive A. 
sobria infection reported from northern Europe. It  is 
reasonable to speculate that she may have acquired the 
bacteria while eating or handling fish caught at the river 
outlet in the Gulf ofBothnia. Aeromonas spp., including 
A. sobria, have been isolated from freshwater fish in 
Sweden and in cold climate areas of the western 
hemisphere [8,9]. These studies have suggested that 
fish could be a potential reservoir for human infection 
[9]. Only a few cases of acute cholecystitis caused by 
Aeromonas spp. have previously been reported in the 
literature [1,4]. The first case due to A .  sobria was 
recently reported from Spain [lo]. As in other cases of 
invasive aeromonas infections, our patient had an 
underlying immunosuppressive illness as well as a 
history of biliary disease [2,4]. 
Acute cholecystitis associated with H. alvei, alone 
or together with other bacteria, has, to our knowledge, 
never been reported before. Hafnia is very rarely 
associated with human disease, although nosocomial 
and community-acquired invasive infections have been 
described, predominantly in patients with underlying 
illnesses [6,11]. The exact source of the H. alvei 
infection in the presented case is unclear, but most 
probably the patient had acquired the bacterium 
outside of the hospital setting. H. alvei has been isolated 
from a variety of environmental sources, animals and 
also fish [5,7]. 
Both A .  sobvia and H .  alvei are in general resistant 
to ampicillin and cefadroxil [1,6]. Susceptibility to 
piperacillin/tazobactam seems to vary among Aeromonas 
spp., while H. alvei is generally considered to be 
piperacillin/tazobactam sensitive [ 1,4,6]. The patient 
recovered rapidly after surgical drainage, in spite of her 
immunosuppressive disorder, inadequate antibiotic 
treatment with cefadroxil and bacterial persistence in 
cultures. This indicates a low pathogenic potential of 
the two bacteria and emphasizes the importance of 
adequate surgical treatment in patients with cho- 
lecystitis not responding to initial empirical antibiotics. 
Third-generation cephalosporins, quinolones or 
aminoglycosides are recommended for treatment of 
aeromonas infections and should also be appropriate for 
treatment of H .  alvei [4,6]. 
In summary, A. sobria and H .  alvei are ubiquitous 
in the environment throughout the world. The pre- 
sented case adds human isolates associated with invasive 
infection for the first time from northern Europe. Both 
bacteria should also be considered as possible causes of 
invasive infections in immunosuppressed patients in 
cold climate areas of the world. 
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all organs [l]. Infection with the human immuno- 
deficiency virus (HIV) has been described in association 
with a wide range of vasculitis syndromes [2]. HIV 
itself, together with the resurgence of many oppor- 
tunistic agents, has increased the interest in microbial 
vasculitis [3]. We present an HIV-1 patient who 
developed Kawasaki syndrome during an acute infection 
with parvovirus B19. 
A 32-year-old-man infected with HIV-1 (whose 
last CD4 count had been 70X1O6/L) was admitted 
because of a 20-day episode of fever, rash, weight loss 
and malaise. Physical examination showed fever (39"C), 
a polymorphous exanthem on the chest, abdomen and 
extensor surfaces of the extremities, particularly the 
palms and soles, a 'strawberry' tongue, non-tender 
cervical lymphadenopathy and hepatosplenomegaly. 
The conjunctivae were red, as were the lips and oral 
cavity. The external genitalia were normal. Laboratory 
results showed: white blood cell (WBC) 13 900/mm3, 
with 81% polymorphonuclear leukocytes (PMLs), 
Kawasaki disease and parvovirus B19 infection in an adult hemoglobin 11.4 g/dL and platelets 220 100/mm3. 
HIV-1 -infected patient Other laboratory parameters were normal. Radio- 
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graphs of the chest and sinuses, abdominal ultrasound, 
ECG and echocardiography were reported as normal. 
Infectious agents of all classes can cause vasculitis in 
arterial and venous blood vessels of all sizes and in 
Cloxacillin 2 g/4 h (IV) and ceftazidime 1 g/6 h were 
started empirically. 
Figure 1 Marked desquamation of fingers. 
